• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI 影像组学:预测直径小于 5cm 肝癌患者经导管动脉化疗栓塞(TACE)后短期疗效的列线图。

MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.

机构信息

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, No. 150 Ximen Street, Linhai, Zhejiang, China.

Sanmen People's Hospital, Taizhou, China.

出版信息

Abdom Radiol (NY). 2021 Aug;46(8):3772-3789. doi: 10.1007/s00261-021-02992-2. Epub 2021 Mar 13.

DOI:10.1007/s00261-021-02992-2
PMID:33713159
Abstract

PURPOSE

To construct MRI radiomics nomograms that can predict short-term response after TACE in HCC patients with diameter less than 5 cm.

METHODS

MRI images and clinical data of 153 cases with tumor diameter less than 5 cm before TACE from 3 hospitals were collected retrospectively and divided into 1 internal training set and 1 external validation set. The T2-weighted imaging (T2WI) and dynamic contrast-enhanced MRI arterial phase (DCE-MR AP) images were studied. Multivariable logistic regression was used to construct Radiomics models, Clinics models, and Nomograms based on T2WI and DCE-MR AP, respectively. The receiver characteristic curve (ROC) was used to evaluate the predictive performance of each model.

RESULTS

In this study, 113 eligible cases in Hospital 1 were collected as the training set, and 40 eligible cases in other hospitals were used as the verification set. 11 T2WI features and 11 DCE-MRI AP features with the most predictive value were finally screened. 3 models based on T2WI and 3 models based on DCE-MRI AP were established, respectively. The area under curve (AUC) value of Nomogram based on T2WI of training set and validation set was 0.83 and 0.81, respectively. The AUC value of the models based on T2WI and models based on AP was almost equal, and Nomograms were the most effective models among all three types of models.

CONCLUSION

MRI-based Nomogram has greater predictive efficacy to predict the response after TACE than Radiomics and Clinics models alone, and the efficacy of T2WI-based models and DCE-MRI AP-based models was almost equal.

摘要

目的

构建 MRI 放射组学列线图,以预测直径小于 5cm 的 HCC 患者 TACE 后短期反应。

方法

回顾性收集 3 家医院 153 例肿瘤直径小于 5cm 的 TACE 前 MRI 图像和临床资料,分为 1 个内部训练集和 1 个外部验证集。研究 T2 加权成像(T2WI)和动态对比增强 MRI 动脉期(DCE-MR AP)图像。基于 T2WI 和 DCE-MR AP,分别采用多变量逻辑回归构建放射组学模型、临床模型和列线图。采用受试者工作特征曲线(ROC)评估各模型的预测性能。

结果

本研究共纳入 1 家医院的 113 例符合条件的病例作为训练集,其他 2 家医院的 40 例符合条件的病例作为验证集。最终筛选出具有最大预测价值的 11 个 T2WI 特征和 11 个 DCE-MRI AP 特征。分别建立了基于 T2WI 和基于 DCE-MRI AP 的 3 个模型。训练集和验证集基于 T2WI 的列线图的曲线下面积(AUC)值分别为 0.83 和 0.81。基于 T2WI 和基于 AP 的模型的 AUC 值几乎相等,列线图是三种模型中最有效的模型。

结论

与单独的放射组学和临床模型相比,基于 MRI 的列线图对 TACE 后反应的预测具有更高的预测效能,基于 T2WI 的模型和 DCE-MRI AP 的模型的疗效几乎相等。

相似文献

1
MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.MRI 影像组学:预测直径小于 5cm 肝癌患者经导管动脉化疗栓塞(TACE)后短期疗效的列线图。
Abdom Radiol (NY). 2021 Aug;46(8):3772-3789. doi: 10.1007/s00261-021-02992-2. Epub 2021 Mar 13.
2
Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.基于 MRI 影像组学的Nomogram 模型预测 TACE 治疗 HCC 的肿瘤应答情况。
Eur Radiol. 2021 Oct;31(10):7500-7511. doi: 10.1007/s00330-021-07910-0. Epub 2021 Apr 16.
3
Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.基于对比增强磁共振成像的放射组学分析预测肝癌药物洗脱微球经导管动脉化疗栓塞术的近期疗效。
Abdom Radiol (NY). 2024 Jul;49(7):2387-2400. doi: 10.1007/s00261-024-04319-3. Epub 2024 Jul 19.
4
Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.基于计算机断层扫描的影像组学列线图用于预测肝细胞癌经动脉化疗栓塞难治性的研究进展
World J Gastroenterol. 2021 Jan 14;27(2):189-207. doi: 10.3748/wjg.v27.i2.189.
5
Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.基于影像组学的 HCC 微血管侵犯预测模型和术后辅助 TACE 获益评估:多中心研究。
Eur Radiol. 2023 Dec;33(12):8936-8947. doi: 10.1007/s00330-023-09824-5. Epub 2023 Jun 27.
6
[Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].基于MRI影像组学模型的乳腺癌HER-2表达状态术前预测
Zhonghua Zhong Liu Za Zhi. 2024 May 23;46(5):428-437. doi: 10.3760/cma.j.cn112152-20230816-00086.
7
Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.基于术前 CT 的放射组学特征预测肝细胞癌经肝动脉化疗栓塞(TACE)治疗的反应。
Cardiovasc Intervent Radiol. 2022 Oct;45(10):1524-1533. doi: 10.1007/s00270-022-03221-z. Epub 2022 Jul 27.
8
Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram.基于深度学习的放射组学列线图无创评估肝细胞癌经导管动脉化疗栓塞治疗的疗效。
Acta Radiol. 2024 Jun;65(6):535-545. doi: 10.1177/02841851241229185. Epub 2024 Mar 15.
9
Prediction of microvascular invasion in hepatocellular carcinoma patients with MRI radiomics based on susceptibility weighted imaging and T2-weighted imaging.基于磁敏感加权成像和 T2 加权成像的 MRI 放射组学预测肝细胞癌患者的微血管侵犯。
Radiol Med. 2024 Aug;129(8):1130-1142. doi: 10.1007/s11547-024-01845-4. Epub 2024 Jul 13.
10
Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.基于增强 MRI 的肿瘤内和肿瘤周围放射组学分析用于术前预测肝细胞癌经动脉化疗栓塞治疗反应。
BMC Cancer. 2023 Oct 24;23(1):1026. doi: 10.1186/s12885-023-11491-0.

引用本文的文献

1
A magnetic resonance imaging radiomics approach predicts hepatocellular carcinoma response to stereotactic body radiation therapy.一种磁共振成像放射组学方法可预测肝细胞癌对立体定向体部放射治疗的反应。
Phys Imaging Radiat Oncol. 2025 Aug 21;35:100826. doi: 10.1016/j.phro.2025.100826. eCollection 2025 Jul.
2
Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Hepatocellular Carcinoma: A Review of Emerging Applications for Locoregional Therapy.肝细胞癌的定量动态对比增强磁共振成像(DCE-MRI):局部区域治疗新兴应用综述
Bioengineering (Basel). 2025 Aug 12;12(8):870. doi: 10.3390/bioengineering12080870.
3

本文引用的文献

1
A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization.一种预测肝细胞癌对经动脉化疗栓塞反应的机器学习模型。
Radiol Artif Intell. 2019 Sep;1(5). doi: 10.1148/ryai.2019180021. Epub 2019 Sep 25.
2
Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.基于增强 CT 的影像组学分析预测肝细胞癌的微血管侵犯及预后
J Hepatol. 2019 Jun;70(6):1133-1144. doi: 10.1016/j.jhep.2019.02.023. Epub 2019 Mar 13.
3
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma.
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE.
基于纵向对比增强磁共振成像的连体网络与机器学习用于预测经动脉化疗栓塞术治疗后肝癌的肿瘤反应
Cancer Imaging. 2025 Aug 19;25(1):104. doi: 10.1186/s40644-025-00926-5.
4
Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics.基于机器学习的影像组学预测免疫检查点抑制剂联合抗血管生成药物治疗不可切除肝细胞癌的预后
BMC Cancer. 2025 May 19;25(1):888. doi: 10.1186/s12885-025-14247-0.
5
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.TRACE模型:预测不可切除肝细胞癌经动脉化疗栓塞术的治疗反应
J Hepatocell Carcinoma. 2025 Jan 29;12:193-203. doi: 10.2147/JHC.S490226. eCollection 2025.
6
Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review.人工智能和机器学习预测经动脉化疗栓塞术的结果:一项系统评价
Dig Dis Sci. 2025 Feb;70(2):533-542. doi: 10.1007/s10620-024-08747-5. Epub 2024 Dec 21.
7
Predicting treatment responses using magnetic resonance imaging-based radiomics in hepatocellular carcinoma patients undergoing transarterial radioembolization.在接受经动脉放射性栓塞治疗的肝细胞癌患者中,使用基于磁共振成像的放射组学预测治疗反应。
Rev Assoc Med Bras (1992). 2024 Dec 2;70(11):e20240721. doi: 10.1590/1806-9282.20240721. eCollection 2024.
8
Multisequence MRI-Based Radiomic Features Combined with Inflammatory Indices for Predicting the Overall Survival of HCC Patients After TACE.基于多序列MRI的影像组学特征联合炎症指标预测肝癌患者经动脉化疗栓塞术后的总生存期
J Hepatocell Carcinoma. 2024 Oct 24;11:2049-2061. doi: 10.2147/JHC.S481301. eCollection 2024.
9
Tumor Growth Pattern and Intra- and Peritumoral Radiomics Combined for Prediction of Initial TACE Outcome in Patients with Primary Hepatocellular Carcinoma.肿瘤生长模式与瘤内及瘤周放射组学联合用于预测原发性肝细胞癌患者经动脉化疗栓塞术的初始疗效
J Hepatocell Carcinoma. 2024 Oct 9;11:1927-1944. doi: 10.2147/JHC.S480554. eCollection 2024.
10
Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.基于放射组学的经动脉化疗栓塞术治疗肝细胞癌的预后预测工具:系统评价和荟萃分析。
Radiol Med. 2024 Aug;129(8):1099-1117. doi: 10.1007/s11547-024-01840-9. Epub 2024 Jul 26.
肝细胞癌微血管侵犯的预后和治疗意义。
Ann Surg Oncol. 2019 May;26(5):1474-1493. doi: 10.1245/s10434-019-07227-9. Epub 2019 Feb 20.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.肝细胞癌经动脉化疗栓塞术的患者选择:获益/风险评估的重要性
Liver Cancer. 2018 Mar;7(1):104-119. doi: 10.1159/000485471. Epub 2018 Jan 12.
6
Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinoma.术后并发症对肝癌根治性切除术后早期复发的预后价值。
Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):323-329. doi: 10.1016/j.hbpd.2018.03.016. Epub 2018 Mar 29.
7
Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization.经临床证实的门静脉高压症对经肝动脉化疗栓塞治疗的肝细胞癌患者临床结局的影响。
J Gastroenterol Hepatol. 2018 Jul;33(7):1397-1406. doi: 10.1111/jgh.14083. Epub 2018 Mar 12.
8
Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.手术治疗肝细胞癌后标本中微血管侵犯的意义。
J Gastroenterol Hepatol. 2018 Feb;33(2):347-354. doi: 10.1111/jgh.13843.
9
Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma.肝细胞癌经动脉化疗栓塞术后完全缓解和复发的预测因素
Gut Liver. 2017 May 15;11(3):409-416. doi: 10.5009/gnl16001.
10
Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma.一种用于肝细胞癌患者微血管侵犯的新型预测评分模型的开发与验证
Eur J Radiol. 2017 Mar;88:32-40. doi: 10.1016/j.ejrad.2016.12.030. Epub 2016 Dec 27.